Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Abstract No: 168 A PHASE 2 RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL TRIAL OF MIL116, A NOVEL 'SWEEPER' ANTI-APRIL MONOCLONAL ANTIBODY, IN PARTICIPANTS WITH IMMUNOGLOBULIN A NEPHROPATHY. Local targets link to admitted publications; unresolved targets remain external evidence.